148 related articles for article (PubMed ID: 31246118)
1. Effect of a two-base insertion mutation of the
Asada H; Tomiyasu H; Goto-Koshino Y; Ohno K; Tsujimoto H
Am J Vet Res; 2019 Jul; 80(7):680-688. PubMed ID: 31246118
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.
Asada H; Tomiyasu H; Okada K; Chambers JK; Goto-Koshino Y; Uchida K; Kagawa Y; Ohno K; Tsujimoto H
Res Vet Sci; 2019 Jun; 124():57-60. PubMed ID: 30852355
[TBL] [Abstract][Full Text] [Related]
3. A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma.
Asada H; Tsuboi M; Chambers JK; Uchida K; Tomiyasu H; Goto-Koshino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2017 Oct; 79(10):1721-1726. PubMed ID: 28867679
[TBL] [Abstract][Full Text] [Related]
4. The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcoma.
Asada H; Ichii O; Tomiyasu H; Uchida K; Chambers JK; Goto-Koshino Y; Ohno K; Kon Y; Tsujimoto H
J Vet Med Sci; 2019 Mar; 81(3):353-356. PubMed ID: 30662044
[TBL] [Abstract][Full Text] [Related]
5. Reduced angiogenic gene expression in morbillivirus-triggered oncolysis in a translational model for histiocytic sarcoma.
Pfankuche VM; Spitzbarth I; Lapp S; Ulrich R; Deschl U; Kalkuhl A; Baumgärtner W; Puff C
J Cell Mol Med; 2017 Apr; 21(4):816-830. PubMed ID: 27860224
[TBL] [Abstract][Full Text] [Related]
6. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
[TBL] [Abstract][Full Text] [Related]
7. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
[TBL] [Abstract][Full Text] [Related]
8. Passage-dependent morphological and phenotypical changes of a canine histiocytic sarcoma cell line (DH82 cells).
Heinrich F; Contioso VB; Stein VM; Carlson R; Tipold A; Ulrich R; Puff C; Baumgärtner W; Spitzbarth I
Vet Immunol Immunopathol; 2015 Jan; 163(1-2):86-92. PubMed ID: 25534080
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
10. p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.
Guillot C; Falette N; Paperin MP; Courtois S; Gentil-Perret A; Treilleux I; Ozturk M; Puisieux A
Oncogene; 1997 Jan; 14(1):45-52. PubMed ID: 9010231
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma.
Tagawa M; Maekawa N; Konnai S; Takagi S
PLoS One; 2016; 11(2):e0150030. PubMed ID: 26901565
[TBL] [Abstract][Full Text] [Related]
13. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.
Barzon L; Gnatta E; Castagliuolo I; Trevisan M; Moretti F; Pontecorvi A; Boscaro M; Palù G
Cancer Gene Ther; 2005 Apr; 12(4):381-8. PubMed ID: 15650765
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of canine SHP2 mutants and anti-tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma.
Tani H; Miyamoto R; Nagashima T; Michishita M; Tamura K; Bonkobara M
Vet Comp Oncol; 2022 Mar; 20(1):109-117. PubMed ID: 34241941
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines.
Yamazaki H; Takagi S; Hoshino Y; Hosoya K; Okumura M
PLoS One; 2013; 8(11):e79810. PubMed ID: 24260303
[TBL] [Abstract][Full Text] [Related]
17. Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status: An Independent Prognostic Factor of Breast Cancer.
Watanabe G; Ishida T; Furuta A; Takahashi S; Watanabe M; Nakata H; Kato S; Ishioka C; Ohuchi N
Am J Surg Pathol; 2015 Aug; 39(8):1026-34. PubMed ID: 26171916
[TBL] [Abstract][Full Text] [Related]
18. Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma.
Ohnstad HO; Castro R; Sun J; Heintz KM; Vassilev LT; Bjerkehagen B; Kresse SH; Meza-Zepeda LA; Myklebost O
Cancer; 2013 Mar; 119(5):1013-22. PubMed ID: 23165797
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress in Canine Histiocytic Sarcoma Cells Induced by an Infection with Canine Distemper Virus Led to a Dysregulation of HIF-1α Downstream Pathway Resulting in a Reduced Expression of VEGF-B in vitro.
Armando F; Gambini M; Corradi A; Giudice C; Pfankuche VM; Brogden G; Attig F; von Köckritz-Blickwede M; Baumgärtner W; Puff C
Viruses; 2020 Feb; 12(2):. PubMed ID: 32054075
[TBL] [Abstract][Full Text] [Related]
20. Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf
Chapeau EA; Gembarska A; Durand EY; Mandon E; Estadieu C; Romanet V; Wiesmann M; Tiedt R; Lehar J; de Weck A; Rad R; Barys L; Jeay S; Ferretti S; Kauffmann A; Sutter E; Grevot A; Moulin P; Murakami M; Sellers WR; Hofmann F; Jensen MR
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3151-3156. PubMed ID: 28265066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]